Donald A. Wiebe

4.9k total citations
67 papers, 3.8k citations indexed

About

Donald A. Wiebe is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cancer Research. According to data from OpenAlex, Donald A. Wiebe has authored 67 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Surgery and 10 papers in Cancer Research. Recurrent topics in Donald A. Wiebe's work include Cancer, Lipids, and Metabolism (10 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers) and Renal Transplantation Outcomes and Treatments (8 papers). Donald A. Wiebe is often cited by papers focused on Cancer, Lipids, and Metabolism (10 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers) and Renal Transplantation Outcomes and Treatments (8 papers). Donald A. Wiebe collaborates with scholars based in United States, United Kingdom and Egypt. Donald A. Wiebe's co-authors include Gary L. Lensmeyer, James H. Stein, Neil Binkley, Jon G. Keevil, Susan E. Aeschlimann, John D. Folts, Jan Feyzi, Richard R. Love, Polly A. Newcomb and Patrick E. McBride and has published in prestigious journals such as Circulation, Annals of Internal Medicine and The Journal of Immunology.

In The Last Decade

Donald A. Wiebe

66 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donald A. Wiebe United States 29 752 679 668 487 463 67 3.8k
Junichi Hasegawa Japan 40 308 0.4× 338 0.5× 527 0.8× 886 1.8× 1.6k 3.5× 363 5.8k
Jordi Camps Spain 46 794 1.1× 177 0.3× 269 0.4× 1.2k 2.5× 1.4k 3.1× 252 7.1k
Marc Conti France 28 633 0.8× 188 0.3× 276 0.4× 389 0.8× 1.0k 2.2× 65 3.3k
Manuel Castro Cabezas Netherlands 37 1.6k 2.2× 208 0.3× 217 0.3× 999 2.1× 732 1.6× 150 5.1k
Roberto Testa Italy 48 1.7k 2.3× 550 0.8× 305 0.5× 1.6k 3.3× 1.5k 3.3× 238 8.3k
Felix Stickel Switzerland 49 1.1k 1.5× 315 0.5× 2.3k 3.4× 960 2.0× 1.9k 4.1× 181 8.4k
Amin A. Nanji United States 45 880 1.2× 184 0.3× 2.9k 4.3× 516 1.1× 1.7k 3.6× 196 6.9k
Giuseppe Palasciano Italy 39 610 0.8× 226 0.3× 362 0.5× 2.2k 4.6× 1.2k 2.7× 178 5.6k
Pankaj B. Desai United States 29 404 0.5× 490 0.7× 982 1.5× 232 0.5× 715 1.5× 81 3.1k
M.F. Oliver United Kingdom 42 913 1.2× 159 0.2× 330 0.5× 1.1k 2.2× 592 1.3× 112 4.6k

Countries citing papers authored by Donald A. Wiebe

Since Specialization
Citations

This map shows the geographic impact of Donald A. Wiebe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald A. Wiebe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald A. Wiebe more than expected).

Fields of papers citing papers by Donald A. Wiebe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald A. Wiebe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald A. Wiebe. The network helps show where Donald A. Wiebe may publish in the future.

Co-authorship network of co-authors of Donald A. Wiebe

This figure shows the co-authorship network connecting the top 25 collaborators of Donald A. Wiebe. A scholar is included among the top collaborators of Donald A. Wiebe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald A. Wiebe. Donald A. Wiebe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kiran, Shumaila, et al.. (2023). Lab Study of High WAT Wax Deposition Reduction with Wax Inhibitors and Dispersants. SPE Annual Technical Conference and Exhibition.
2.
Allen, David B., et al.. (2016). Development of filter paper hemoglobin A1c assay applicable to newborn screening. Clinica Chimica Acta. 457. 24–26. 7 indexed citations
3.
Hedman, Curtis J., et al.. (2014). Development of a sensitive LC/MS/MS method for vitamin D metabolites: 1,25 Dihydroxyvitamin D2&3 measurement using a novel derivatization agent. Journal of Chromatography B. 953-954. 62–67. 79 indexed citations
4.
Binkley, Neil & Donald A. Wiebe. (2013). Clinical Controversies in Vitamin D: 25(OH)D Measurement, Target Concentration, and Supplementation. Journal of Clinical Densitometry. 16(4). 402–408. 27 indexed citations
5.
Binkley, Neil, Diane Krueger, Sarah Morgan, & Donald A. Wiebe. (2010). Current status of clinical 25-hydroxyvitamin D measurement: An assessment of between-laboratory agreement. Clinica Chimica Acta. 411(23-24). 1976–1982. 67 indexed citations
6.
Lensmeyer, Gary L., Donald A. Wiebe, Neil Binkley, & Marc K. Drezner. (2006). The authors of the article cited above respond:. Clinical Chemistry. 52(12). 2305–2306. 7 indexed citations
7.
Keevil, Jon G., et al.. (2001). Effect of ingestion of purple grape juice on endothelial function in patients with coronary heart disease. The American Journal of Cardiology. 88(5). 553–555. 101 indexed citations
8.
Krueger, Christian G., et al.. (2001). Cranberry proanthocyanidins associate with low‐density lipoprotein and inhibit in vitro Cu2+‐induced oxidation. Journal of the Science of Food and Agriculture. 81(14). 1306–1313. 76 indexed citations
9.
Allen, Todd M., John Sidney, Marie‐France del Guercio, et al.. (1998). Characterization of the Peptide Binding Motif of a Rhesus MHC Class I Molecule (Mamu-A*01) That Binds an Immunodominant CTL Epitope from Simian Immunodeficiency Virus. The Journal of Immunology. 160(12). 6062–6071. 194 indexed citations
10.
Lensmeyer, Gary L., Donald A. Wiebe, Ian H. Carlson, & Ramiah Subramanian. (1991). Concentrations of Cyclosporin A and Its Metabolites in Human Tissues Postmortem. Journal of Analytical Toxicology. 15(3). 110–115. 46 indexed citations
11.
Lensmeyer, Gary L., et al.. (1990). Three commercial polyclonal immunoassays for cyclosporine in whole blood compared: 2. Cross-reactivity of the antisera with cyclosporine metabolites.. PubMed. 36(1). 119–23. 12 indexed citations
12.
Wiebe, Donald A., et al.. (1990). Fatal Intravenous Injection of Monooctanoin. American Journal of Forensic Medicine & Pathology. 11(2). 165–170. 3 indexed citations
13.
Newcomb, Polly A., Donald A. Wiebe, Tanya Surawicz, et al.. (1990). Effects of Tamoxifen Therapy on Lipid and Lipoprotein Levels in Postmenopausal Patients With Node-Negative Breast Cancer. JNCI Journal of the National Cancer Institute. 82(16). 1327–1332. 228 indexed citations
14.
Vrabec, Michael P., et al.. (1988). Ophthalmic Observations in Lecithin Cholesterol Acyltransferase Deficiency. Archives of Ophthalmology. 106(2). 225–229. 11 indexed citations
15.
Wiebe, Donald A., et al.. (1987). Plasma lipoprotein changes in humans induced by β-interferon. Atherosclerosis. 67(2-3). 261–267. 34 indexed citations
16.
Borden, Ernest C., et al.. (1986). Effects of Recombinant Interferon-α 2 Treatment upon Lipid Concentrations and Lipoprotein Composition. Journal of Interferon Research. 6(6). 655–662. 35 indexed citations
17.
Wiebe, Donald A. & John T. Bernert. (1984). Influence of incomplete cholesteryl ester hydrolysis on enzymic measurements of cholesterol.. Clinical Chemistry. 30(3). 352–356. 41 indexed citations
18.
Chaves‐Carballo, Enrique, et al.. (1979). Triglyceride and Cholesterol Concentrations in Whole Serum and in Serum Lipoproteins in Reye Syndrome. PEDIATRICS. 64(5). 592–597. 9 indexed citations
19.
Burns, C. Patrick, et al.. (1977). Fatty acid utilization by L1210 murine leukemia cells.. PubMed. 37(7 Pt 1). 1991–7. 15 indexed citations
20.
Naae, Douglas G. & Donald A. Wiebe. (1974). Mass spectral correlations of halogenated 1,1,1,3,3,3‐hexafluoropropanes and 1,1,1‐trifluoroethanes. Organic Mass Spectrometry. 9(12). 1203–1206. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Junichi Hasegawa Breakdown of academic impact, for papers by Jordi Camps Breakdown of academic impact, for papers by Marc Conti Breakdown of academic impact, for papers by Manuel Castro Cabezas Breakdown of academic impact, for papers by Roberto Testa Breakdown of academic impact, for papers by Felix Stickel Breakdown of academic impact, for papers by Amin A. Nanji Breakdown of academic impact, for papers by Giuseppe Palasciano Breakdown of academic impact, for papers by Pankaj B. Desai Breakdown of academic impact, for papers by M.F. Oliver
Rankless by CCL
2026